Poland
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
361.41%
|
Dec. 31, 2023 | USD 1.01 | 1.23% |
|
Poland |
|
2 |
38.45%
|
Dec. 31, 2023 | USD 2.34 | 1.69% |
|
Poland |
|
3 |
36.20%
|
Dec. 31, 2023 | USD 11.11 | -3.75% |
|
Poland |
|
4 |
35.71%
|
Dec. 31, 2023 | USD 29.80 | 1.98% |
|
Poland |
|
5 |
25.41%
|
Dec. 31, 2023 | USD 1.05 | -1.52% |
|
Poland |
|
6 |
24.17%
|
Dec. 31, 2023 | USD 0.77 | 0.43% |
|
Poland |
|
7 |
20.08%
|
Sept. 30, 2024 | USD 50.91 | 0.74% |
|
Poland |
|
8 |
19.90%
|
Dec. 31, 2023 | USD 6.09 | -0.44% |
|
Poland |
|
9 |
14.73%
|
Dec. 31, 2023 | USD 4.92 | 2.76% |
|
Poland |
|
10 |
8.60%
|
Dec. 31, 2023 | USD 2.77 | 0.74% |
|
Poland |
|
11 |
7.02%
|
Dec. 31, 2023 | USD 2.77 | 1.63% |
|
Poland |
|
12 |
5.19%
|
Dec. 31, 2023 | USD 4.27 | -3.25% |
|
Poland |
|
13 |
4.14%
|
Dec. 31, 2023 | USD 12.79 | 0.55% |
|
Poland |
|
14 |
3.40%
|
Dec. 31, 2023 | USD 204.85 | 1.34% |
|
Poland |
|
15 |
-172.95%
|
Dec. 31, 2023 | USD 7.78 | -9.75% |
|
Poland |
|
16 |
-490.60%
|
Dec. 31, 2023 | USD 10.54 | 0.97% |
|
Poland |
|
17 |
-833.38%
|
Dec. 31, 2023 | USD 9.29 | -3.28% |
|
Poland |
|
18 |
-2,100.89%
|
Dec. 31, 2023 | USD 1.85 | -0.17% |
|
Poland |
|
19 |
-3,342.44%
|
Dec. 31, 2023 | USD 40.10 | -0.57% |
|
Poland |
|
20 |
-27,449.47%
|
Dec. 31, 2023 | USD 3.73 | -0.03% |
|
Poland |
|
21 |
-389,809.76%
|
Dec. 31, 2023 | USD 0.79 | 1.05% |
|
Poland |
|
22 |
-775,600.00%
|
Dec. 31, 2023 | USD 1.74 | 1.31% |
|
Poland |
|
23 |
-16,413,896.00%
|
Dec. 31, 2023 | USD 2.23 | 1.07% |
|
Poland |
The Health Care company in Poland with the highest EBITDA Margin is Pharmena S.A. (Warsaw Stock Exchange: PHR.WA) at 361.41%.
The Health Care company in Poland with the lowest EBITDA Margin is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at -16,413,896.00%.
The top 10 Health Care companies in Poland by EBITDA Margin are Pharmena S.A., Mabion S.A., Selvita S.A., Voxel S.A., Synthaverse S.A., BIOTON S.A., Synektik Spólka Akcyjna, Celon Pharma S.A., Centrum Medyczne ENEL-MED S.A. and EMC Instytut Medyczny SA.
The bottom 10 Health Care companies in Poland by EBITDA Margin are Molecure S.A., Genomtec S.A., NanoGroup S.A., Pure Biologics Spólka Akcyjna, Scope Fluidics S.A., Medinice S.A., Poltreg S.A., Captor Therapeutics Spolka Akcyjna, Ryvu Therapeutics S.A. and NEUCA S.A..